XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating expenses    
General and administrative $ 5,856,609 $ 6,846,599
Research and development 25,231,623 22,260,349
Total operating expenses (31,088,232) (29,106,948)
Other income (expenses)    
Grant income 149,888 298,943
Research and development incentive income 4,375,025 2,465,691
Interest income, net 179,973 207,280
Gain on settlement of accounts payable 0 115,758
Financing related charges 0 (151,133)
Foreign exchange gain (loss), net 125,540 (42,389)
Total other income, net 4,830,426 2,894,150
Net loss before provision for income taxes (26,257,806) (26,212,798)
Income tax expense, current (22,664) (82,181)
Net loss and comprehensive loss $ (26,280,470) $ (26,294,979)
Net Loss per share    
Basic and diluted $ (0.45) $ (0.54)
Weighted average number of shares outstanding    
Basic and diluted 58,194,894 48,906,470